These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20831495)

  • 1. Hypofractionation does not increase radiation pneumonitis risk with modern conformal radiation delivery techniques.
    Vogelius IS; Westerly DC; Cannon GM; Bentzen SM
    Acta Oncol; 2010 Oct; 49(7):1052-7. PubMed ID: 20831495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
    Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
    Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC.
    Cattaneo GM; Dell'oca I; Broggi S; Fiorino C; Perna L; Pasetti M; Sangalli G; di Muzio N; Fazio F; Calandrino R
    Radiother Oncol; 2008 Sep; 88(3):310-8. PubMed ID: 18692266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
    Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
    Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
    Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
    Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; PĂ©rol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
    Vogelius IS; Westerly DC; Cannon GM; Mackie TR; Mehta MP; Sugie C; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):893-9. PubMed ID: 21477946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans.
    Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H
    Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.
    Mavroidis P; Shi C; Plataniotis GA; Delichas MG; Ferreira BC; Rodriguez S; Lind BK; Papanikolaou N
    Br J Radiol; 2011 Feb; 84(998):161-72. PubMed ID: 20858664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
    Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
    Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
    Han C; Schultheiss TE; Wong JYC
    Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer.
    Manon RR; Jaradat H; Patel R; Zhang T; Fenwick J; Tome W; Fowler J; Paliwal B; Soisson E; Yuan Z; Mehta M
    Clin Lung Cancer; 2005 Sep; 7(2):107-13. PubMed ID: 16179097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.